Using these transgenic mice, we identified and generated leukemias that model MYC overexpression via three different mechanisms: single copy gain (resulting from trisomy 15), retroviral expression of an activating mutation of FLT3, and retroviral overexpression of MYC as a model of gene amplification. The gene discussed is MYC; the disease is leukemia.